Recombinants in thrombosis and hemostasis: From basic research to clinical therapy

Seminars in Thrombosis and Hemostasis

Volumn 36, Issue 5, 2010, Pages 471-476

  Lippi, Giuseppe ^a   Favaloro, Emmanuel J ^b  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; CONTINUOUS ERYTHROPOIESIS RECEPTOR ACTIVATOR; DESMOPRESSIN; DNA; PLASMA PROTEIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT BLOOD CLOTTING FACTOR 9; RECOMBINANT PROTEIN; RECOMBINANT VON WILLEBRAND FACTOR; RNA; TENECTEPLASE; THROMBIN; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR CLEAVING PROTEINASE; BLOOD CLOTTING FACTOR;

BACTERIOPHAGE; BACTERIUM; BASIC RESEARCH; BRAIN ISCHEMIA; CAUTERIZATION; CELL CULTURE; DISEASE TRANSMISSION; DNA SEQUENCE; EDITORIAL; FIBRINOLYTIC THERAPY; FUNGUS; GENE THERAPY; GENETIC ENGINEERING; HEMOPHILIA; HEMOSTASIS; HEPARINIZATION; HUMAN; IMMUNOGENICITY; INSECT; LIGATION; LUNG EMBOLISM; MAMMAL CELL; NONHUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PLANT; PRIORITY JOURNAL; RECOMBINANT DNA TECHNOLOGY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURGICAL TECHNIQUE; THROMBOSIS; VENOUS THROMBOEMBOLISM; YEAST; DRUG EFFECTS; MEDICAL RESEARCH;

BIOMEDICAL RESEARCH; BLOOD COAGULATION FACTORS; HEMOSTASIS; HUMANS; RECOMBINANT PROTEINS; THROMBOSIS;

EID: 77954876447     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0030-1255440     Document Type: Editorial

References (40)

1. Bowman L J., Anderson C D., Chapman W C. Topical recombinant human thrombin in surgical hemostasis. Semin Thromb Hemost 2010 36 (5) 477-484
2. Favaloro E J., Posen J, Ramakrishna R et al. Factor V inhibitors: rare or not so uncommon? A multi-laboratory investigation. Blood Coagul Fibrinolysis 2004 15 (8) 637-647
3. Lawson J H. The clinical use and immunologic impact of thrombin in surgery. Semin Thromb Hemost 2006 32 (Suppl 1) 98-110
4. Guideline on the clinical investigation of plasma derived fibrin sealant/haemostatic products (CPMP/BPWG/1089/00). Committee for medicinal products for human use (CHMP). European Medicines Agency. Available at: http://www.ema.europa.eu/pdfs/human/bpwg/108900en.pdf Accessed April 24, 2010
5. Franchini M, Lippi G. Recombinant activated factor VII: mechanisms of action and current indications. Semin Thromb Hemost 2010 36 (5) 485-492
6. Franchini M, Manzato F, Salvagno G L., Montagnana M, Zaffanello M, Lippi G. Prophylaxis in congenital hemophilia with inhibitors: the role of recombinant activated factor VII. Semin Thromb Hemost 2009 35 (8) 814-819
7. Franchini M, Franchi M, Bergamini V, Salvagno G L., Montagnana M, Lippi G. A critical review on the use of recombinant factor VIIa in life-threatening obstetric postpartum hemorrhage. Semin Thromb Hemost 2008 34 (1) 104-112
8. Franchini M, Favaloro E J., Lippi G. Glanzmann thrombasthenia: an update. Clin Chim Acta 2010 411 (12) 1-6
9. Gouw S C., van den Berg H M. The multifactorial etiology of inhibitor development in hemophilia: genetics and environment. Semin Thromb Hemost 2009 35 (8) 723-734
10. Favaloro E J. Identification, pathogenesis, and treatment of factor inhibitors. Semin Thromb Hemost 2009 35 (8) 719-722
11. Ananyeva N M., Lee T K., Jain N, Shima M, Saenko E L. Inhibitors in hemophilia A: advances in elucidation of inhibitory mechanisms and in inhibitor management with bypassing agents. Semin Thromb Hemost 2009 35 (8) 735-751
12. Franchini M, Lippi G. Recent improvements in the clinical treatment of coagulation factor inhibitors. Semin Thromb Hemost 2009 35 (8) 806-813
13. Mathews V, Nair S C., David S, Viswabandya A, Srivastava A. Management of hemophilia in patients with inhibitors: the perspective from developing countries. Semin Thromb Hemost 2009 35 (8) 820-826
14. Lippi G, Franchini M, Favaloro E J. One-stage clotting versus chromogenic assays for assessing recombinant factor VIII: two faces of a haemostasis coin. Blood Coagul Fibrinolysis 2009 20 1-3
15. Viiala N O., Larsen S R., Rasko J E. Gene therapy for hemophilia: clinical trials and technical tribulations. Semin Thromb Hemost 2009 35 (1) 81-92
16. Monahan P E., Di Paola J. Recombinant factor IX for clinical and research use. Semin Thromb Hemost 2010 36 (5) 498-509
17. Plaimauer B, Schlokat U, Turecek P L. et al. Recombinant von Willebrand factor: preclinical development. Semin Thromb Hemost 2001 27 (4) 395-403
18. Schwarz H P., Schlokat U, Mitterer A et al. Recombinant von Willebrand factor-insight into structure and function through infusion studies in animals with severe von Willebrand disease. Semin Thromb Hemost 2002 28 (2) 215-226
19. Zhou Z, Nguyen T C., Guchhait P, Dong J F. Von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura. Semin Thromb Hemost 2010 36 (1) 71-81
20. Franchini M, Mannucci P M. Von Willebrand factor: another janus-faced hemostasis protein. Semin Thromb Hemost 2008 34 (7) 663-669
21. Franchini M, Montagnana M, Targher G, Lippi G. Reduced von Willebrand factor-cleaving protease levels in secondary thrombotic microangiopathies and other diseases. Semin Thromb Hemost 2007 33 (8) 787-797
22. Favaloro E J. Toward a new paradigm for the identification and functional characterization of von Willebrand disease. Semin Thromb Hemost 2009 35 (1) 60-75
23. Turecek P L., Schrenk G, Rottensteiner H, Varadi K, Bevers E, Lenting P, Ilk N, Sleytr U B., Ehrlich H J., Schwarz H P. Structure and function of a recombinant von Willebrand factor (VWF) drug candidate. Semin Thromb Hemost 2010 36 (5) 510-521
24. Muchitsch E, Dietrich B, Rottensteiner H, Auer W, Nehrbass D, Gritsch H, Ehrlich H J., Turecek P L., Schwarz H P. Pre-clinical testing of human recombinant von Willebrand factor: ADAMTS13 cleavage capacity in animals as criterion for species suitability. Semin Thromb Hemost 2010 36 (5) 522-528
25. Douma R A., Kamphuisen P W. Thrombolysis for pulmonary embolism and venous thrombosis: is it worthwhile? Semin Thromb Hemost 2007 33 (8) 821-828
26. Campbell J, Hilleman D E. Recombinant peptides in thrombolysis. Semin Thromb Hemost 2010 36 (5) 529-536
27. Lippi G, Franchini M, Favaloro E J. Thrombotic complications of erythropoiesis-stimulating agents. Semin Thromb Hemost 2010 36 (5) 537-549
28. Levi M, Lowenberg E, Meijers J C. Recombinant anticoagulant factors for adjunctive treatment of sepsis. Semin Thromb Hemost 2010 36 (5) 550-557
29. Lippi G, Favaloro E J. Recombinant platelet factor 4: a therapeutic, anti-neoplastic chimera? Semin Thromb Hemost 2010 36 (5) 558-569
30. Lippi G, Plebani M, Franchini M, Guidi G C., Favaloro E J. Prostate-specific antigen, prostate cancer, and disorders of hemostasis. Semin Thromb Hemost 2009 35 (7) 654-664
31. Franchini M, Montagnana M, Favaloro E J., Lippi G. The bidirectional relationship of cancer and hemostasis and the potential role of anticoagulant therapy in moderating thrombosis and cancer spread. Semin Thromb Hemost 2009 35 (7) 644-653
32. Snyder K M., Kessler C M. The pivotal role of thrombin in cancer biology and tumorigenesis. Semin Thromb Hemost 2008 34 (8) 734-741
33. Miesbach W. Antiphospholipid antibodies and antiphospholipid syndrome in patients with malignancies: features, incidence, identification, and treatment. Semin Thromb Hemost 2008 34 (3) 282-285
34. Lechner D, Weltermann A. Chemotherapy-induced thrombosis: a role for microparticles and tissue factor? Semin Thromb Hemost 2008 34 (2) 199-203
35. Nadir Y, Vlodavsky I, Brenner B. Heparanase, tissue factor, and cancer. Semin Thromb Hemost 2008 34 (2) 187-194
36. Milsom C, Yu J, May L, Magnus N, Rak J. Diverse roles of tissue factor-expressing cell subsets in tumor progression. Semin Thromb Hemost 2008 34 (2) 170-181
37. Signaevsky M, Hobbs J, Doll J, Liu N, Soff G A. Role of alternatively spliced tissue factor in pancreatic cancer growth and angiogenesis. Semin Thromb Hemost 2008 34 (2) 161-169
38. Palumbo J S. Mechanisms linking tumor cell-associated procoagulant function to tumor dissemination. Semin Thromb Hemost 2008 34 (2) 154-160
39. Schaffner F, Ruf W. Tissue factor and protease-activated receptor signaling in cancer. Semin Thromb Hemost 2008 34 (2) 147-153
40. Rickles F R., Brenner B. Tissue factor and cancer. Semin Thromb Hemost 2008 34 (2) 143-145